MCID: PNM007
MIFTS: 72

Pneumonia

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Pneumonia

MalaCards integrated aliases for Pneumonia:

Name: Pneumonia 12 77 30 56 6 44 45 15 17 74 3 3 64 64
Acute Pneumonia 12 74

Classifications:



External Ids:

Disease Ontology 12 DOID:552
MeSH 45 D011014
NCIt 51 C3333
SNOMED-CT 69 60363000

Summaries for Pneumonia

MedlinePlus : 44 Pneumonia is an infection in one or both of the lungs. Many germs, such as bacteria, viruses, and fungi, can cause pneumonia. You can also get pneumonia by inhaling a liquid or chemical. People most at risk are older than 65 or younger than 2 years of age, or already have health problems. Symptoms of pneumonia vary from mild to severe. See your doctor promptly if you Have a high fever Have shaking chills Have a cough with phlegm that doesn't improve or gets worse Develop shortness of breath with normal daily activities Have chest pain when you breathe or cough Feel suddenly worse after a cold or the flu Your doctor will use your medical history, a physical exam, and lab tests to diagnose pneumonia. Treatment depends on what kind you have. If bacteria are the cause, antibiotics should help. If you have viral pneumonia, your doctor may prescribe an antiviral medicine to treat it. Preventing pneumonia is always better than treating it. Vaccines are available to prevent pneumococcal pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Pneumonia, also known as acute pneumonia, is related to mycoplasma pneumoniae pneumonia and bacterial pneumonia, and has symptoms including fever, pruritus and hemoptysis. An important gene associated with Pneumonia is TTR (Transthyretin), and among its related pathways/superpathways are Innate Immune System and Akt Signaling. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and heart, and related phenotypes are cardiovascular system and homeostasis/metabolism

Disease Ontology : 12 A lung disease that involves lung parenchyma or alveolar inflammation and abnormal alveolar filling with fluid (consolidation and exudation). It results from a variety of causes including infection with bacteria, viruses, fungi or parasites, and chemical or physical injury to the lungs. It is accompanied by fever, chills, cough, and difficulty in breathing.

CDC : 3 Pneumocystis pneumonia (PCP) is a serious infection caused by the fungus Pneumocystis jirovecii.

PubMed Health : 64 About pneumonia: Pneumonia (nu-MO-ne-ah) is an infection in one or both of the lungs. Many germs—such as bacteria, viruses, and fungi—can cause pneumonia.The infection inflames your lungs' air sacs, which are called alveoli (al-VEE-uhl-eye). The air sacs may fill up with fluid or pus, causing symptoms such as a cough with phlegm (a slimy substance), fever, chills, and trouble breathing.

Wikipedia : 77 Pneumonia is an inflammatory condition of the lung affecting primarily the small air sacs known as... more...

Related Diseases for Pneumonia

Diseases in the Pneumonia family:

Viral Pneumonia Bacterial Pneumonia

Diseases related to Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1385)
# Related Disease Score Top Affiliating Genes
1 mycoplasma pneumoniae pneumonia 34.8 CRP IL10 IL6 TLR2 TNF
2 bacterial pneumonia 34.6 CRP CXCL8 ELANE IL6 SFTPD TLR4
3 idiopathic interstitial pneumonia 34.2 CCL2 CXCL8 ELANE MUC5B SFTPC SFTPD
4 pneumocystosis 34.1 CD40LG SFTPD TNF
5 pulmonary fibrosis, idiopathic 33.4 CCL2 CXCL8 ELANE IL1B MUC5B SFTPC
6 bronchiolitis obliterans 32.9 CXCL8 IL10 IL6 TNF
7 q fever 32.8 IL10 IL1B IL6 TLR2 TLR4 TNF
8 avian influenza 32.8 CXCL8 IL6 SFTPD TNF
9 bronchiolitis 32.6 CRP CXCL8 IL10 IL6 MUC5B TLR4
10 melioidosis 32.6 IL10 IL6 TLR2 TLR4 TLR5 TNF
11 legionellosis 32.6 IL1B TLR2 TLR4 TLR5 TNF
12 invasive aspergillosis 32.4 CXCL8 SFTPD TLR2 TLR4
13 extrinsic allergic alveolitis 32.4 CCL2 CXCL8 IL10 IL1B IL6 MPO
14 adult respiratory distress syndrome 32.4 CXCL8 ELANE IL10 IL6 SFTPC TNF
15 toxic shock syndrome 32.3 CXCL8 IL10 IL1B IL6 TLR2 TLR4
16 respiratory failure 32.3 CRP CXCL8 ELANE SFTPC SFTPD TNF
17 irak4 deficiency 32.3 TLR2 TLR4 TLR5
18 myd88 deficiency 32.3 TLR2 TLR4 TLR5
19 chlamydia 32.1 CRP CXCL8 IL10 IL1B IL6 TLR2
20 interstitial lung disease 32.1 CCL2 CXCL8 IL10 IL1B IL6 MUC5B
21 common variable immunodeficiency 32.0 CD40LG FOXP3 IL10 IL6 TLR2 TNF
22 lung disease 31.8 CCL2 CXCL8 ELANE IL10 IL1B IL6
23 omenn syndrome 31.8 FOXP3 IL10 TNF
24 bronchitis 31.8 CRP CXCL8 ELANE MPO TNF
25 haemophilus influenzae 31.8 CXCL8 IL1B TLR2 TNF
26 acquired immunodeficiency syndrome 31.6 IL10 IL1B IL6 TNF
27 arthritis 31.4 CCL2 CXCL8 IL10 IL1B IL6 TNF
28 human immunodeficiency virus infectious disease 31.4 IL10 IL6 TNF
29 meningitis 31.3 CCL2 CRP CXCL8 IL10 IL1B IL6
30 pulmonary fibrosis 31.3 CCL2 IL1B MUC5B SFTPC SFTPD
31 fasciitis 31.2 CXCL8 IL6 TNF
32 heart disease 31.2 CRP CXCL8 IL10 IL1B IL6 TNF
33 purpura 31.2 CRP IL6 TNF
34 hematopoietic stem cell transplantation 31.2 IL10 IL6 TNF
35 otitis media 31.2 CXCL8 IL10 IL1B IL6 MUC5B TLR2
36 arteries, anomalies of 31.2 CCL2 CRP IL1B IL6 TNF
37 pulmonary tuberculosis 31.1 IL10 TLR2 TNF
38 acute respiratory distress syndrome 31.1 CXCL8 ELANE IL1B IL6 SFTPC SFTPD
39 lupus erythematosus 31.1 CD40LG IL10 TLR5 TNF
40 myocarditis 31.1 CD40LG IL6 TNF
41 acute cystitis 31.1 CCL2 CRP CXCL8 IL6
42 pericarditis 31.1 CRP IL1B IL6 TNF
43 viral infectious disease 31.0 CD40LG CXCL8 IL10 IL1B IL6 TNF
44 spondylitis 31.0 CRP IL6 TNF
45 burns 31.0 IL1B TNF TTR
46 connective tissue disease 31.0 CD40LG IL10 IL6 SFTPD TNF
47 endocarditis 31.0 CRP CXCL8 IL10 IL6 TLR2 TNF
48 spondyloarthropathy 1 31.0 CRP TLR4 TNF
49 duodenal ulcer 30.9 CXCL8 IL1B TNF
50 asthma 30.9 CCL2 CD40LG CXCL8 ELANE IL10 IL1B

Graphical network of the top 20 diseases related to Pneumonia:



Diseases related to Pneumonia

Symptoms & Phenotypes for Pneumonia

UMLS symptoms related to Pneumonia:


fever, pruritus, hemoptysis, snoring, coughing

MGI Mouse Phenotypes related to Pneumonia:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.29 CD40LG CRP FOXP3 IL10 IL1B IL6
2 homeostasis/metabolism MP:0005376 10.28 CD40LG CRP ELANE FOXP3 IL10 IL1B
3 immune system MP:0005387 10.27 CCL2 CD40LG CRP ELANE FOXP3 IL10
4 hematopoietic system MP:0005397 10.25 CD40LG ELANE FOXP3 IL10 IL1B IL6
5 digestive/alimentary MP:0005381 10.06 FOXP3 IL10 IL6 TLR2 TLR4 TLR5
6 mortality/aging MP:0010768 10 CD40LG ELANE FOXP3 IL10 IL1B IL6
7 integument MP:0010771 9.92 CD40LG FOXP3 IL10 IL1B IL6 TLR2
8 liver/biliary system MP:0005370 9.8 FOXP3 IL10 IL6 TLR2 TLR4 TLR5
9 neoplasm MP:0002006 9.56 ELANE IL10 IL1B IL6 SFTPC TLR2
10 respiratory system MP:0005388 9.32 FOXP3 IL10 IL6 MUC5B SFTPC SFTPD

Drugs & Therapeutics for Pneumonia

PubMedHealth treatment related to Pneumonia: 64

Treatment for pneumonia depends on the type of pneumonia you have and how severe it is. Most people who have community-acquired pneumonia—the most common type of pneumonia—are treated at home.The goals of treatment are to cure the infection and prevent complications.

FDA approved drugs:

(show all 7)
# Drug Name Active Ingredient(s) 19 Company Approval Date
1
Augmentin 19 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 19 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Teflaro 19 CEFTAROLINE FOSAMIL Cerexa Nov-10
4
Tequin 19 Bristol-Myers Squibb December, 1999
5
Tygacil 19 TIGECYCLINE Wyeth 2005
6
Vibativ 19 * TELAVANCIN * TELAVANCIN HYDROCHLORIDE Theravance June 2013
7
Zosyn 19 PIPERACILLIN SODIUM; TAZOBACTAM SODIUM Wyeth May 1996

Drugs for Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 1099)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vancomycin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1404-90-6 441141 14969
2
Tobramycin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 32986-56-4 5496 36294
3
Levofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 100986-85-4 149096
4
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
5
Ofloxacin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 82419-36-1 4583
6
Linezolid Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 165800-03-3 441401
7
Clavulanate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 58001-44-8 5280980
8
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 26787-78-0 33613
9
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
10
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
11
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
13
Cilastatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 82009-34-5 6435415 5280454
14
Imipenem Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 74431-23-5, 64221-86-9 104838
15
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 354812-41-2, 151096-09-2 152946
16
Metronidazole Approved Phase 4,Phase 3,Phase 2,Not Applicable 443-48-1 4173
17
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Not Applicable 57-63-6 5991
18
Norgestimate Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 35189-28-7 6540478
19
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Not Applicable 28014-46-2
20
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-28-2 5757
21
Ethanol Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 64-17-5 702
22
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55-56-1 2713 9552079
23
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
24
Colistin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1264-72-8, 1066-17-7 5311054
25
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 53-03-2 5865
26
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 22916-47-8 4189
27
Calcium Carbonate Approved, Investigational Phase 4 471-34-1
28
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 6055-19-2, 50-18-0 2907
29
Ganciclovir Approved, Investigational Phase 4,Phase 1,Phase 2,Not Applicable 82410-32-0 3454
30
Acyclovir Approved Phase 4,Phase 2 59277-89-3 2022
31
Penicillin G Approved, Vet_approved Phase 4,Phase 3 61-33-6 5904
32
Ciprofloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 85721-33-1 2764
33
Tazobactam Approved Phase 4,Phase 2,Phase 3,Phase 1 89786-04-9 123630
34
Clarithromycin Approved Phase 4,Phase 3,Phase 2 81103-11-9 84029
35
Cefuroxime Approved Phase 4,Phase 3,Phase 2,Not Applicable 55268-75-2 5361202 5479529
36
Piperacillin Approved Phase 4,Phase 2,Phase 3 66258-76-2 43672
37
Trimethoprim Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 738-70-5 5578
38
Sulfamethoxazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 723-46-6 5329
39
Bosentan Approved, Investigational Phase 4,Phase 3,Phase 2 147536-97-8 104865
40 Strawberry Approved Phase 4,Phase 3
41
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
42
Cefotaxime Approved Phase 4,Phase 3,Phase 2,Not Applicable 63527-52-6 456256 5742673
43
Cefoxitin Approved Phase 4,Phase 2 35607-66-0 441199
44
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 73590-58-6 4594
45
Budesonide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51333-22-3 63006 5281004
46 Beractant Approved Phase 4 108778-82-1
47
tannic acid Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 1401-55-4
48
Atropine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-55-8, 5908-99-6 174174
49
Neostigmine Approved, Vet_approved Phase 4,Not Applicable 59-99-4 4456
50
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 437-38-7 3345

Interventional clinical trials:

(show top 50) (show all 3651)
# Name Status NCT ID Phase Drugs
1 Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients Unknown status NCT01501227 Phase 4
2 Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia Unknown status NCT02478710 Phase 4 Aerosolized Tobramycin or Vancomycin;Aerosolized Placebo
3 Clinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatients Unknown status NCT02600806 Phase 4 Azithromycin;Levofloxacin
4 Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia Unknown status NCT01805284 Phase 4 Linezolid
5 Trial on the Ideal Duration of Oral Antibiotics in Children With Pneumonia Unknown status NCT02258763 Phase 4 Amoxicillin-Potassium Clavulanate Combination;Placebo
6 Corticosteroid Therapy for Severe Community-Acquired Pneumonia Unknown status NCT02552342 Phase 4 methylprednisolone;Normal saline
7 Probiotics for Prevention of Ventilator-Associated Pneumonia (VAP) Unknown status NCT01301131 Phase 4
8 Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia Unknown status NCT02440828 Phase 4 tobramycin inhalation;placebo
9 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
10 Ventilator-associated Pneumonia (VAP) and Humidification System Unknown status NCT01546974 Phase 4
11 Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia Unknown status NCT01356472 Phase 4 Imipenem/cilastatin
12 Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors Unknown status NCT00752947 Phase 4 moxifloxacin;levofloxacin;metronidazole
13 Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children. Unknown status NCT01883596 Phase 4 0.12% chlorhexidine solution;Placebo
14 Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1)Pneumonia: Multi-centre, Prospective, Randomized Controlled Study Unknown status NCT00936013 Phase 4 oseltamivir;oseltamivir and chinese medicinal herbs
15 SDD for Eradicating CRKP Carriage Unknown status NCT01761487 Phase 4
16 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4 Cyclosporin A;Prednisone;Placebo;Calcium carbonate D
17 PTH - Preemptive Treatment for Herpesviridae Unknown status NCT02152358 Phase 4 Aciclovir;Ganciclovir;Placebo
18 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
19 Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections Unknown status NCT02171338 Phase 4
20 Lactobacillus Preparation on the Incidence of Diarrhea Unknown status NCT01792739 Phase 4 Lactobacillus casei variety rhamnosus granules;Placebo
21 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
22 Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau Unknown status NCT02953327 Phase 4
23 Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Unknown status NCT00152802 Phase 4
24 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
25 Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda Unknown status NCT00674921 Phase 4 cotrimoxazole;Placebo
26 Safety and Efficacy Study of High Dose Colistin Unknown status NCT02162966 Phase 4 High Dose Colistin;Standard Dose Colistin
27 Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study Unknown status NCT00637065 Phase 4 Bosentan;Placebo
28 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
29 Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) Patients Unknown status NCT01131806 Phase 4 fluticasone/ salmeterol 125/25 mcg/puff;fluticasone/ salmeterol 250/25 mcg/puff
30 LGG for Prevention of Infectious Complications During PPI Treatment in Children Unknown status NCT01782118 Phase 4
31 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
32 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
33 Prevention of Chronic Lung Disease (CLD) in Preterm Infants Unknown status NCT00883532 Phase 4 budesonide;surfactant and air (placebo)
34 Recovery of Muscle Function After Deep Neuromuscular Block by Means of Diaphragm Ultrasonography Unknown status NCT02698969 Phase 4 Sugammadex;Neostigmine;Atropine;Rocuronium;Fentanyl;Propofol;Sevoflurane
35 Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication Unknown status NCT02198625 Phase 4
36 Comparative Study of Non-Invasive Mask Ventilation vs Cuirass Ventilation in Patients With Acute Respiratory Failure. Unknown status NCT00331656 Phase 4
37 Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD Unknown status NCT02504801 Phase 4 Budesonide
38 Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS) Unknown status NCT01573715 Phase 4 NIMBEX;NIMBEX
39 Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients Unknown status NCT01657487 Phase 4 Fluticasone/Salmeterol high dose
40 Effect of Enteral Genistein Supplementation in Sepsis Unknown status NCT02796794 Phase 4
41 Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery Unknown status NCT02958566 Phase 4 Acetaminophen;Gabapentin;Orphenadrine;Lidocaine;Marcaine;Ketamine;Methadone;Tramadol;Ketorolac;Morphine Sulfate;Fentanyl;Dilaudid;Hydrocodone-Acetaminophen Tab 5-325 MG;Morphine Sulfate;Fentanyl;Dilaudid;HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET
42 Polysaccharide Antibody Response Study Unknown status NCT02429531 Phase 4
43 Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis Unknown status NCT03132623 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
44 Influence of BCG on TDaP-IPV Vaccination Unknown status NCT02771782 Phase 4
45 Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients Unknown status NCT01104896 Phase 4 Nicotine patch;Placebo
46 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
47 A Study of Residual Curarization Incidence in China Unknown status NCT01690338 Phase 4 Vecuronium Bromide;Rocuronium;Cisatracurium
48 Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients Unknown status NCT01382368 Phase 4 Sildenafil
49 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
50 Correlation Among Sperm DNA Fragmentation, Genitourinary Infection by Mycoplasma in Male and the Pregnancy Outcomes After IUI in Their Partner Unknown status NCT01555047 Phase 4

Search NIH Clinical Center for Pneumonia

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: pneumonia

Genetic Tests for Pneumonia

Genetic tests related to Pneumonia:

# Genetic test Affiliating Genes
1 Pneumonia 30

Anatomical Context for Pneumonia

MalaCards organs/tissues related to Pneumonia:

42
Lung, Testes, Heart, Breast, Skin, Colon, Neutrophil

Publications for Pneumonia

Articles related to Pneumonia:

(show top 50) (show all 12140)
# Title Authors Year
1
Acute Encephalopathy With Biphasic Seizures and Late Reduced Diffusion Associated With Adenoviral Pneumonia. ( 30783608 )
2019
2
Up-regulation of THY1 attenuates interstitial pulmonary fibrosis and promotes lung fibroblast apoptosis during acute interstitial pneumonia by blockade of the WNT signaling pathway. ( 30829553 )
2019
3
Re: Association of the Hospital Readmissions Reduction Program with Mortality among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia. ( 30888900 )
2019
4
Relationship Between Patient-Reported Hospital Experience and 30-Day Mortality and Readmission Rates for Acute Myocardial Infarction, Heart Failure, and Pneumonia. ( 30746641 )
2019
5
Gender disparities among hospitalised patients with acute myocardial infarction, acute decompensated heart failure or pneumonia: retrospective cohort study. ( 30670508 )
2019
6
EXPRESS: Analysis of Pulmonary Vascular Injury and Repair during Pseudomonas aeruginosa Infection-induced Pneumonia and Acute Respiratory Distress Syndrome. ( 30632898 )
2019
7
Neutrophil Extracellular Traps Are Elevated in Patients with Pneumonia-related Acute Respiratory Distress Syndrome. ( 30676417 )
2019
8
Allergic bronchopulmonary aspergillosis in succession to chronic eosinophilic pneumonia. ( 30670338 )
2019
9
Increased risk of rheumatoid arthritis among patients with Mycoplasma pneumonia: A nationwide population-based cohort study in Taiwan. ( 30640923 )
2019
10
A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib. ( 30533376 )
2019
11
Organizing pneumonia in a patient with rheumatoid arthritis with progression to usual interstitial pneumonia. ( 30295895 )
2019
12
Aspiration Pneumonia. ( 30763196 )
2019
13
Aspiration Pneumonia in Older Adults. ( 30794136 )
2019
14
Clinical and radiographic findings in cats with aspiration pneumonia: retrospective evaluation of 28 cases. ( 30843218 )
2019
15
Meconium aspiration pneumonia and otitis media in two goat kids. ( 30852957 )
2019
16
The Mortality and the Risk of Aspiration Pneumonia Related with Dysphagia in Stroke Patients. ( 30857927 )
2019
17
Risk factors and prognostic implications of aspiration pneumonia in older hip fracture patients: A multicenter retrospective analysis. ( 30556343 )
2019
18
Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung. ( 30676341 )
2019
19
Why are people with asthma susceptible to pneumonia? A review of factors related to upper airway bacteria. ( 30887658 )
2019
20
Anti-interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis. ( 30574332 )
2019
21
Lung Ultrasound for the Emergency Diagnosis of Pneumonia, Acute Heart Failure, and Exacerbations of Chronic Obstructive Pulmonary Disease/Asthma in Adults: A Systematic Review and Meta-analysis. ( 30314929 )
2019
22
Performance of the CHA2DS2-VASc score in predicting new onset atrial fibrillation during hospitalization for community-acquired pneumonia. ( 30692019 )
2019
23
Pulmonary alveolar proteinosis developing during steroid treatment in a patient with organizing pneumonia in association with atypical chronic myeloid leukemia. ( 30899476 )
2019
24
The burden of community-acquired bacterial pneumonia in the era of antibiotic resistance. ( 30596308 )
2019
25
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. ( 30649434 )
2019
26
ABL kinase inhibition promotes lung regeneration through expansion of an SCGB1A1+ SPC+ cell population following bacterial pneumonia. ( 30655340 )
2019
27
Recurrent bacterial pneumonia in Irish Wolfhounds: Clinical findings and etiological studies. ( 30666726 )
2019
28
Antibacterial Activity of Lefamulin Against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015-2016). ( 30670415 )
2019
29
Efficacy and Safety of IV-to-Oral Lefamulin, a Pleuromutilin Antibiotic, for Treatment of Community-Acquired Bacterial Pneumonia: The Phase 3 LEAP 1 Trial. ( 30722059 )
2019
30
Omadacycline for Community-Acquired Bacterial Pneumonia. ( 30726692 )
2019
31
A spatial analysis of geographic variation and factors associated with hospitalization for bacterial pneumonia in Korea. ( 30786908 )
2019
32
Solithromycin monotherapy for treatment of community-acquired bacterial pneumonia: a meta-analysis of randomized controlled trials. ( 30810253 )
2019
33
Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016). ( 30843070 )
2019
34
Computational screening of potential drug targets for pathogens causing bacterial pneumonia. ( 30914386 )
2019
35
Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin. ( 30626817 )
2019
36
Isolated Cystic Lung Disease: An Algorithmic Approach to Distinguishing Birt-Hogg-Dubé Syndrome, Lymphangioleiomyomatosis, and Lymphocytic Interstitial Pneumonia. ( 30888864 )
2019
37
Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer: A case report. ( 30608451 )
2019
38
Traction bronchiectasis on high-resolution computed tomography may predict fatal acute eosinophilic pneumonia. ( 30528687 )
2019
39
Provider Knowledge, Attitudes, and Practices Regarding Bronchiolitis and Pneumonia Guidelines. ( 30610012 )
2019
40
Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation - Clues to a potential mechanism. ( 30792952 )
2019
41
Outbreak of Chlamydia pneumoniae Infections and X-ray-Confirmed Pneumonia in Army Trainees at Fort Leonard Wood, Missouri, 2014. ( 30690452 )
2019
42
Round pneumonia due to Chlamydia pneumoniae in a child. ( 30701012 )
2019
43
New evidence for domesticated animals as reservoirs of Chlamydia-associated community-acquired pneumonia. ( 30394363 )
2019
44
Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis. ( 30380910 )
2019
45
Predictive factors for relapse of cryptogenic organizing pneumonia. ( 30626371 )
2019
46
Cryptogenic Organizing Pneumonia Presenting as a Solitary Mass: Clinical, Imaging, and Pathologic Features. ( 30648699 )
2019
47
Pneumonia-associated death in patients with dementia: A systematic review and meta-analysis. ( 30870526 )
2019
48
Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1γ-positive dermatomyositis. ( 30906559 )
2019
49
Successful treatment with intravenous high-dose immunoglobulin for cardiomyopathy in dermatomyositis complicated with rapid progressive interstitial pneumonia. ( 26443969 )
2019
50
Anti-Ku antibody-positive desquamative interstitial pneumonia. ( 30603599 )
2019